Software rules unclear in EU device proposals
This article was originally published in SRA
Executive Summary
A lack of clarity over how the European Commission's proposed regulations on medical devices and in vitro diagnostics would regulate software are among the myriad concerns that stakeholders have raised in response to a consultation issued by the UK Medicines and Healthcare products Regulatory Agency1,2.